{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:38:11Z","timestamp":1776580691727,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.urolonc.2026.111079","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T12:12:44Z","timestamp":1774181564000},"page":"111079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pelvic lymph node dissection in prostate cancer: still an indication?"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6859-9409","authenticated-orcid":false,"given":"Federico","family":"Ferraris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Yaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.111079_bib0001","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1245\/s10434-007-9360-5","article-title":"Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data","volume":"14","author":"Gervasoni","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111079_bib0002","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.urolonc.2024.09.024","article-title":"Oncologic outcomes of pelvic organ-preserving radical cystectomy vs. standard radical cystectomy: a systematic review and meta-analysis","volume":"43","author":"Hinojosa-Gonzalez","year":"2025","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111079_bib0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111079_bib0004","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111079_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.111079_bib0006","unstructured":"European Association of Urology. 2026 EAU Guidelines on Prostate Cancer [Internet]. 2026 [cited 2026 Mar 20]. Available from: http:\/\/uroweb.org\/guidelines\/prostatecancer"},{"issue":"11","key":"10.1016\/j.urolonc.2026.111079_bib0007","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"issue":"suppl 16","key":"10.1016\/j.urolonc.2026.111079_bib0008","article-title":"64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer","volume":"41","author":"Lengyelova","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111079_bib0009","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/JU.0000000000003043","article-title":"Radioisotope-guided lymphadenectomy for pelvic lymph node staging in patients with intermediate- and high-risk prostate cancer (The Prospective SENTINELLE Study)","volume":"209","author":"Lannes","year":"2023","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111079_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2007.04.020","article-title":"Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy","volume":"52","author":"Heidenreich","year":"2007","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:39:33Z","timestamp":1776577173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1078143926000906"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111079","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pelvic lymph node dissection in prostate cancer: still an indication?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111079"}}